Skip to main content

AI in drug discovery – what it is, where we stand and the path forward

Hacker NewsUnconfirmed

Why AI in drug discovery – what it is, where we stand and the path forward matters

Drug discovery represents a significant application domain for AI/ML practitioners to understand; organizations evaluating AI's ROI in biotech and pharma should track how academic and industry research is validating AI's concrete impact on discovery timelines and cost.

Read the full article at Hacker News

CoFabrix summarises and comments on this story. The original reporting belongs to Hacker News.

More in Research

Browse the full AI Pulse feed

Seeing AI Disruption in Your Industry?

Find out where your organization stands -- and what to do about it.